Lv42
540 积分 2023-01-17 加入
Impact of sodium glucose cotransporter 2 inhibitors on bladder cancer and breast cancer: a pharmacovigilance analysis and Mendelian randomization study
5天前
已完结
SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes
11天前
已完结
Osmotic nephropathy induced by SGLT2 inhibitor overdose
11天前
已关闭
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials
11天前
已完结
Empagliflozin versus DPP4i or GLP ‐ 1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study
11天前
已完结
Special vascular risk with Canagliflozin
11天前
已完结
Vildagliptin-Associated Acquired Hemophilia A
11天前
已完结
Comparative Risk of Glaucoma in Patients Using Sodium-glucose Cotransporter-2 Inhibitors and Metformin: A Multinational Cohort Study
11天前
已关闭
Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms
11天前
已完结
Embryotoxic and Oxidative Impact of Dapagliflozin: A Dose‐Dependent Study Using a Chick Embryo Model
11天前
已完结
皖公网安备34019202002308
